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Abstract 
Background: More than half of the world’s population is at risk of malaria and simultaneously, many malaria-
endemic regions are facing dramatic increases in the prevalence of type 2 diabetes. Studies in murine malaria models 
have examined the impact of malaria infection on type 2 diabetes pathology, it remains unclear how this chronic 
metabolic disorder impacts the transmission of malaria. In this report, the ability type 2 diabetic rodents infected with 
malaria to transmit parasites to Anopheles stephensi mosquitoes is quantified.
Methods: The infection prevalence and intensity of An. stephensi mosquitoes that fed upon control or type 2 diabetic 
C57BL/6 db/db mice infected with either lethal Plasmodium berghei NK65 or non-lethal Plasmodium yoelii 17XNL 
murine malaria strains were determined. Daily parasitaemias were also recorded.
Results: A higher percentage of mosquitoes (87.5 vs 61.5 % for P. yoelii and 76.9 vs 50 % for P. berghei) became 
infected following blood feeding on Plasmodium-infected type 2 diabetic mice compared to mosquitoes that fed on 
infected control animals, despite no significant differences in circulating gametocyte levels.
Conclusions: These results suggest that type 2 diabetic mice infected with malaria are more efficient at infecting 
mosquitoes, raising the question of whether a similar synergy exists in humans.
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Background
It is currently estimated that 22 million people are living 
with type 2 diabetes (T2D) on the African continent and 
this population is projected to double by 2030 [1]. Con-
currently, there are over 250 million new malaria cases 
worldwide, the majority of which occur on the African 
continent. In contrast to developed countries, where the 
prevalence of T2D is greatest in individuals >60  years 
old, T2D in lesser developed countries is highly preva-
lent in individuals 40–60 years old [2], suggesting a dura-
ble epidemiological impact of T2D-associated increased 
malaria risk [3]. The rising prevalence of T2D in these 
regions can largely be ascribed to changes in lifestyle and 
urbanization, resulting in greater levels of obesity and 
physical inactivity [4, 5]. Published reports have shown 
that patients with T2D are 46 % more likely to be infected 
with Plasmodium falciparum [3]. Yet, the impact of T2D 
on malaria transmission remains unexamined.
Interestingly, Plasmodium infection improves glucose 
homeostasis in humans [6, 7], and in murine models of 
T2D it appears that glycosylphosphatidylinositols (GPIs) 
of the parasite are able to mimic the effects of endog-
enous insulin signalling [8–10]. Previous studies have 
examined the development of asexual stage Plasmodium 
in T2D mice and noted delayed development of parasi-
taemia [10, 11] and a correlation between obesity and 
increased resistance to cerebral malaria [11]. Therefore in 
a rodent model, T2D hosts with malaria may have altered 
duration and/or intensity of infection, possibly making 
them more efficient disease reservoirs. Although these 
studies clearly demonstrated that T2D and obesity can 
impact circulating levels of asexual parasites in mice, to 
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date no published studies have examined the effects of 
T2D on malaria transmission to mosquitoes in any mam-
malian system. The evidence to suggest an effect of T2D 
on malaria transmission comes primarily from murine 
experiments, thus these experiments were conducted 
in similar models. This study provides the first evidence 
that a metabolic disorder can enhance transmission of 




Anopheles stephensi (Indian strain) were reared and 
maintained at 27  °C and 80  % humidity. All mosquito 
rearing and feeding protocols were approved and in 
accordance with regulatory guidelines and standards set 
by the University of California Davis Institutional Ani-
mal Care and Use Committee. For transmission studies, 
50 laboratory-reared, 3- to 5-day old, female mosquitoes 
were kept on water overnight and then allowed to feed 
for 15 min on anesthetized Plasmodium-infected animals 
prior to peak parasitaemia. Non-blood-fed mosquitoes 
were removed and after 10 days, midguts from mosqui-
toes were dissected into PBS and stained with 0.1 % mer-
curochrome for direct counting of Plasmodium oocysts.
Mice
All animal experiments were approved by the UC Davis 
Institutional Animal Care and Use Committee and were 
performed in accordance with institutional guidelines 
on animal welfare. Six week-old female C57BL/6J and 
C57BL/6J db/db (B6.BKS(D)-Leprdb/J) mice were pur-
chased from the Jackson Laboratories (Bar Harbor, ME, 
USA). Female CD-1 mice were purchased from Harlan 
Laboratories (Haslett, MI, USA). All mice were main-
tained in standard cages and received standard rodent 
chow (PMI lab chow number 5001) and sterile drinking 
water ad libitum.
Parasites
Plasmodium yoelii yoelii 17XNL and Plasmodium berghei 
NK65 stocks were obtained from BEI Resources Malaria 
Research and Reference Reagent Resource (Manas-
sas, VA, USA). Parasite stocks were made by passage in 
CD-1 mice. Mice were inoculated intraperitoneally with 
~1  ×  106 infected red blood cells (RBCs) in 0.1  ml of 
saline. Daily percentages of parasitaemia in mice were 
calculated by counting the number of infected RBCs and 
dividing this number by the total number of RBCs in 
thin blood films stained with Giemsa (Sigma-Aldrich). 
Gametocytaemia was determined by visually quantifying 
gametocyte stage parasites and dividing this number by 
the total number of infected RBCs.
Statistics
For mosquito transmission studies, data were analysed 
using Mann–Whitney test. Differences in prevalence of 
infection were determined by Chi square test. For para-
sitaemia and gametocytaemia, data were analysed by Stu-
dent’s t test.
Results
Similar to previously published reports, T2D mice 
infected with lethal P. berghei had decreased parasitae-
mias compared to infected wild-type controls, but game-
tocytaemias were no different from controls, except at 
day 4 post-infection (Fig.  1a, b). However, mosquitoes 
that fed upon P. berghei-infected T2D mice at day 5 post-
infection had more than ten times the mean number of 
oocysts per positive midgut (Fig. 1c) compared to mos-
quitoes fed on infected wild-type mice. Further, nearly 
60  % more mosquitoes were infected with at least one 
oocyst (Fig. 1d) after feeding on infected T2D mice com-
pared to wild-type mice. In contrast, T2D mice infected 
with non-lethal P. yoelii parasites had significantly higher 
parasitaemias at day 8 compared to wild-type controls 
(Fig. 1e), but like P. berghei-infected mice, showed no sig-
nificant differences in gametocytaemias (Fig.  1f ). Inter-
estingly, mosquitoes that fed upon P. yoelii-infected T2D 
and wild-type mice showed no differences in infection 
intensity (Fig.  1g). As with P. berghei, however, signifi-
cantly more mosquitoes were infected with at least one 
oocyst following feeding on P. yoelii-infected T2D mice 
compared to infected wild-type mice (Fig.  1h). Thus, 
enhanced transmission was observed from T2D mice 
infected with lethal and non-lethal strains of malaria 
parasites.
Discussion
These are the first data to show that T2D enhances the 
transmission of malaria parasites to a mosquito vec-
tor in a rodent model. In these studies, P. berghei NK65 
were used as model for lethal cerebral malaria that 
more commonly affects children, and P. yoelii 17XNL, 
a model for non-lethal infection that is more typical 
of disease in adults. Increased transmission from T2D 
mice was observed, using different strains of murine 
malaria parasites with very different disease patholo-
gies. Interestingly, no differences in infection intensity 
where observed in mosquitoes that fed upon P. yoelii-
infected T2D and wild-type mice (Fig. 1g). This finding 
suggests that the factors that affect gametocyte develop-
ment in the mosquito in a non-lethal P. yoelii infection 
are different than in a lethal P. berghei infection. Further 
studies are required to elucidate what these factors are 
and how they impact gametocyte development in the 
mosquito.
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Plasmodium gametocytogenesis is defined by a suc-
cession of developmental stages, of which only mature 
male and female gametocytes are infectious to mosqui-
toes. Mature P. yoelii gametocytes sequester primarily in 
sub-dermal capillaries of the skin in mice, which provides 
protection from splenic clearance and promotes inges-
tion by mosquitoes during blood feeding [12]. Hosts 
with no detectable or sub-microscopic gametocytaemia 
retain the ability to infect mosquitoes, suggesting that 
significant numbers of mature gametocytes sequester in 
the skin [12–15]. As in data shown here, the association 
between circulating gametocyte densities in the mam-
malian host and infectivity to mosquitoes is not always 
linear [16]. Notably, altered parasite sequestration that 
is not correlated with peripheral gametocytaemia could 
contribute to enhanced transmission from T2D mice 
relative to wild-type mice. Therefore, future studies will 
examine if specific alterations in parasite sequestration 
occur in diabetic animals.
As the population of adults suffering from T2D con-
tinues to increase in malaria-endemic regions, these 
findings suggest that this co-morbidity could impact 
treatment and control efforts for both diseases in these 
regions. Indeed, health systems in low-resource countries 
have largely focused on acute rather than chronic care, 
which coupled with limited care access and delayed diag-
nosis of T2D contributes to more severe T2D disease and 
complications at the time of diagnosis [1]. Despite pre-
dictions that malaria-endemic African and Asian nations 
will face steeply rising incidences of T2D, few published 
reports have examined this co-morbidity. Indeed, beyond 
the activity of Plasmodium GPIs as insulin mimetics [8–
10], little is known of how malaria might alter the pathol-
ogy of T2D and how treatment of T2D might impact 
malaria infection and, more specifically, transmission. 
Thus, further investigations of T2D and malaria co-mor-
bidity could inform future health interventions for these 
diseases.
Conclusion
Type 2 diabetic mice infected with either P. yoelii or P. 
berghei resulted in a higher prevalence of infected An. ste-
phensi when compared to wild-type controls. These mice 
also had significantly lower parasitaemias but no signifi-
cant differences in circulating gametocyte levels. These 
data suggest that this co-morbidity in humans could 
significantly alter the infectious reservoir and transmis-
sion of malaria and should therefore be examined more 
closely.
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Fig. 1 Parasitaemias, gametocytaemias and parasite transmission from wild-type (WT) and type 2 diabetic (T2D) C57BL/6 mice infected with 
malaria. a, e Parasitaemias and b, f gametocytaemias (mean ± SEM) were determined by visual counts from Giemsa-stained slides prepared from 
tail bleeds. n = 4–6, *p ≤ 0.05). c, d, g, h Prior to peak parasitaemia (day 5 for Plasmodium berghei and day 8 for Plasmodium yoelii yoelii 17XNL), mice 
were anesthetized and 50 mosquitoes/mouse were allowed to feed for 15 min. Mosquitoes were maintained on 10 % sucrose for 10 days at which 
point midguts were dissected and oocysts counted. n = 30–70 mosquitoes, *p ≤ 0.05
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